JP2020508663A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020508663A5 JP2020508663A5 JP2019545731A JP2019545731A JP2020508663A5 JP 2020508663 A5 JP2020508663 A5 JP 2020508663A5 JP 2019545731 A JP2019545731 A JP 2019545731A JP 2019545731 A JP2019545731 A JP 2019545731A JP 2020508663 A5 JP2020508663 A5 JP 2020508663A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- fragment
- antibody
- tumor
- binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 claims 72
- 102000036639 antigens Human genes 0.000 claims 70
- 108091007433 antigens Proteins 0.000 claims 70
- 206010028980 Neoplasm Diseases 0.000 claims 57
- 239000012634 fragment Substances 0.000 claims 54
- 230000003302 anti-idiotype Effects 0.000 claims 44
- 210000004027 cell Anatomy 0.000 claims 38
- 108020001507 fusion proteins Proteins 0.000 claims 30
- 102000037865 fusion proteins Human genes 0.000 claims 30
- -1 TMPRSS-3 / 4 Proteins 0.000 claims 22
- 108090000765 processed proteins & peptides Proteins 0.000 claims 21
- 102000025171 antigen binding proteins Human genes 0.000 claims 16
- 108091000831 antigen binding proteins Proteins 0.000 claims 16
- 102100023635 Alpha-fetoprotein Human genes 0.000 claims 12
- 108010072866 Prostate-Specific Antigen Proteins 0.000 claims 12
- 102100038358 Prostate-specific antigen Human genes 0.000 claims 12
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 claims 9
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 claims 8
- 101710123134 Ice-binding protein Proteins 0.000 claims 8
- 101710082837 Ice-structuring protein Proteins 0.000 claims 8
- 108010017842 Telomerase Proteins 0.000 claims 8
- 101710107540 Type-2 ice-structuring protein Proteins 0.000 claims 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 8
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims 6
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 6
- 102100026094 C-type lectin domain family 12 member A Human genes 0.000 claims 6
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 claims 6
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims 6
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims 6
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 6
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims 6
- 229940125644 antibody drug Drugs 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 230000001939 inductive effect Effects 0.000 claims 6
- 238000012737 microarray-based gene expression Methods 0.000 claims 6
- 238000012243 multiplex automated genomic engineering Methods 0.000 claims 6
- 229920001481 poly(stearyl methacrylate) Polymers 0.000 claims 6
- 102000005962 receptors Human genes 0.000 claims 6
- 108020003175 receptors Proteins 0.000 claims 6
- 102000010956 Glypican Human genes 0.000 claims 5
- 108050001154 Glypican Proteins 0.000 claims 5
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 claims 4
- 101800000504 3C-like protease Proteins 0.000 claims 4
- 102100036464 Activated RNA polymerase II transcriptional coactivator p15 Human genes 0.000 claims 4
- 101710145634 Antigen 1 Proteins 0.000 claims 4
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims 4
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims 4
- 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 claims 4
- 102100025570 Cancer/testis antigen 1 Human genes 0.000 claims 4
- 102100024423 Carbonic anhydrase 9 Human genes 0.000 claims 4
- 102000013392 Carboxylesterase Human genes 0.000 claims 4
- 108010051152 Carboxylesterase Proteins 0.000 claims 4
- 101150029707 ERBB2 gene Proteins 0.000 claims 4
- 102000004190 Enzymes Human genes 0.000 claims 4
- 108090000790 Enzymes Proteins 0.000 claims 4
- 102100035139 Folate receptor alpha Human genes 0.000 claims 4
- 108050007237 Glypican-3 Proteins 0.000 claims 4
- 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 claims 4
- 101001023230 Homo sapiens Folate receptor alpha Proteins 0.000 claims 4
- 101001014223 Homo sapiens MAPK/MAK/MRK overlapping kinase Proteins 0.000 claims 4
- 101000623901 Homo sapiens Mucin-16 Proteins 0.000 claims 4
- 108010031794 IGF Type 1 Receptor Proteins 0.000 claims 4
- 102000004877 Insulin Human genes 0.000 claims 4
- 108090001061 Insulin Proteins 0.000 claims 4
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 claims 4
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 claims 4
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 claims 4
- 102100034872 Kallikrein-4 Human genes 0.000 claims 4
- 108010028275 Leukocyte Elastase Proteins 0.000 claims 4
- 102000016799 Leukocyte elastase Human genes 0.000 claims 4
- 102100031520 MAPK/MAK/MRK overlapping kinase Human genes 0.000 claims 4
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims 4
- 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 claims 4
- 102100022430 Melanocyte protein PMEL Human genes 0.000 claims 4
- 102100023123 Mucin-16 Human genes 0.000 claims 4
- 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 claims 4
- 206010060862 Prostate cancer Diseases 0.000 claims 4
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 4
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 4
- 108010002687 Survivin Proteins 0.000 claims 4
- 102100033504 Thyroglobulin Human genes 0.000 claims 4
- 108010034949 Thyroglobulin Proteins 0.000 claims 4
- 108010026331 alpha-Fetoproteins Proteins 0.000 claims 4
- 229940088598 enzyme Drugs 0.000 claims 4
- 239000003102 growth factor Substances 0.000 claims 4
- 229940084986 human chorionic gonadotropin Drugs 0.000 claims 4
- 210000002865 immune cell Anatomy 0.000 claims 4
- 229940125396 insulin Drugs 0.000 claims 4
- 230000000968 intestinal effect Effects 0.000 claims 4
- 108010024383 kallikrein 4 Proteins 0.000 claims 4
- 230000000873 masking effect Effects 0.000 claims 4
- 101800000607 p15 Proteins 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 238000010839 reverse transcription Methods 0.000 claims 4
- 239000000758 substrate Substances 0.000 claims 4
- 101150047061 tag-72 gene Proteins 0.000 claims 4
- 229940124597 therapeutic agent Drugs 0.000 claims 4
- 229960002175 thyroglobulin Drugs 0.000 claims 4
- 101710188619 C-type lectin domain family 12 member A Proteins 0.000 claims 3
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 claims 3
- 208000032612 Glial tumor Diseases 0.000 claims 3
- 206010018338 Glioma Diseases 0.000 claims 3
- 101000912622 Homo sapiens C-type lectin domain family 12 member A Proteins 0.000 claims 3
- 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 claims 3
- 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 claims 3
- 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 claims 3
- 102000003735 Mesothelin Human genes 0.000 claims 3
- 108090000015 Mesothelin Proteins 0.000 claims 3
- 230000001086 cytosolic effect Effects 0.000 claims 3
- 239000013604 expression vector Substances 0.000 claims 3
- 210000000822 natural killer cell Anatomy 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 230000011664 signaling Effects 0.000 claims 3
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 claims 2
- WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 claims 2
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 claims 2
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 claims 2
- 101710163573 5-hydroxyisourate hydrolase Proteins 0.000 claims 2
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 claims 2
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 claims 2
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 claims 2
- 102000030431 Asparaginyl endopeptidase Human genes 0.000 claims 2
- 102100035526 B melanoma antigen 1 Human genes 0.000 claims 2
- 102100025218 B-cell differentiation antigen CD72 Human genes 0.000 claims 2
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 2
- 102000015735 Beta-catenin Human genes 0.000 claims 2
- 108060000903 Beta-catenin Proteins 0.000 claims 2
- 102100024210 CD166 antigen Human genes 0.000 claims 2
- 102100024220 CD180 antigen Human genes 0.000 claims 2
- 102100025221 CD70 antigen Human genes 0.000 claims 2
- 102100036369 Carbonic anhydrase 6 Human genes 0.000 claims 2
- 102000011727 Caspases Human genes 0.000 claims 2
- 108010076667 Caspases Proteins 0.000 claims 2
- 102000005600 Cathepsins Human genes 0.000 claims 2
- 108010084457 Cathepsins Proteins 0.000 claims 2
- 102100039496 Choline transporter-like protein 4 Human genes 0.000 claims 2
- 102100024292 Cryptic family protein 1B Human genes 0.000 claims 2
- 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 claims 2
- 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 claims 2
- 108010055196 EphA2 Receptor Proteins 0.000 claims 2
- 102100030340 Ephrin type-A receptor 2 Human genes 0.000 claims 2
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 claims 2
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims 2
- 102100028073 Fibroblast growth factor 5 Human genes 0.000 claims 2
- 108090000380 Fibroblast growth factor 5 Proteins 0.000 claims 2
- 102100039717 G antigen 1 Human genes 0.000 claims 2
- 101710113436 GTPase KRas Proteins 0.000 claims 2
- 102100040510 Galectin-3-binding protein Human genes 0.000 claims 2
- 101710197901 Galectin-3-binding protein Proteins 0.000 claims 2
- 101710088083 Glomulin Proteins 0.000 claims 2
- 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 claims 2
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 claims 2
- 101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 claims 2
- 101000934359 Homo sapiens B-cell differentiation antigen CD72 Proteins 0.000 claims 2
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 2
- 101100165850 Homo sapiens CA9 gene Proteins 0.000 claims 2
- 101000980840 Homo sapiens CD166 antigen Proteins 0.000 claims 2
- 101000980829 Homo sapiens CD180 antigen Proteins 0.000 claims 2
- 101000934356 Homo sapiens CD70 antigen Proteins 0.000 claims 2
- 101000714525 Homo sapiens Carbonic anhydrase 6 Proteins 0.000 claims 2
- 101000910338 Homo sapiens Carbonic anhydrase 9 Proteins 0.000 claims 2
- 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 claims 2
- 101000980071 Homo sapiens Cryptic family protein 1B Proteins 0.000 claims 2
- 101000886137 Homo sapiens G antigen 1 Proteins 0.000 claims 2
- 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 claims 2
- 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 claims 2
- 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 claims 2
- 101000934372 Homo sapiens Macrosialin Proteins 0.000 claims 2
- 101000620359 Homo sapiens Melanocyte protein PMEL Proteins 0.000 claims 2
- 101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 claims 2
- 101000628547 Homo sapiens Metalloreductase STEAP1 Proteins 0.000 claims 2
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims 2
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 claims 2
- 101001051490 Homo sapiens Neural cell adhesion molecule L1 Proteins 0.000 claims 2
- 101000851058 Homo sapiens Neutrophil elastase Proteins 0.000 claims 2
- 101000610551 Homo sapiens Prominin-1 Proteins 0.000 claims 2
- 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 claims 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 2
- 101001062222 Homo sapiens Receptor-binding cancer antigen expressed on SiSo cells Proteins 0.000 claims 2
- 101000973629 Homo sapiens Ribosome quality control complex subunit NEMF Proteins 0.000 claims 2
- 101000874179 Homo sapiens Syndecan-1 Proteins 0.000 claims 2
- 101000847107 Homo sapiens Tetraspanin-8 Proteins 0.000 claims 2
- 101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 claims 2
- 101000904724 Homo sapiens Transmembrane glycoprotein NMB Proteins 0.000 claims 2
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims 2
- 101000671653 Homo sapiens U3 small nucleolar RNA-associated protein 14 homolog A Proteins 0.000 claims 2
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 claims 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 claims 2
- 241000701806 Human papillomavirus Species 0.000 claims 2
- 108010052919 Hydroxyethylthiazole kinase Proteins 0.000 claims 2
- 108010027436 Hydroxymethylpyrimidine kinase Proteins 0.000 claims 2
- 108010030506 Integrin alpha6beta4 Proteins 0.000 claims 2
- 102100020793 Interleukin-13 receptor subunit alpha-2 Human genes 0.000 claims 2
- 101710112634 Interleukin-13 receptor subunit alpha-2 Proteins 0.000 claims 2
- 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 claims 2
- 102100031413 L-dopachrome tautomerase Human genes 0.000 claims 2
- 101710093778 L-dopachrome tautomerase Proteins 0.000 claims 2
- 102100031586 Leukocyte antigen CD37 Human genes 0.000 claims 2
- 108010010995 MART-1 Antigen Proteins 0.000 claims 2
- 102000016200 MART-1 Antigen Human genes 0.000 claims 2
- 102100025136 Macrosialin Human genes 0.000 claims 2
- 108010076557 Matrix Metalloproteinase 14 Proteins 0.000 claims 2
- 102100030216 Matrix metalloproteinase-14 Human genes 0.000 claims 2
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 claims 2
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 claims 2
- 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 claims 2
- 102100026712 Metalloreductase STEAP1 Human genes 0.000 claims 2
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims 2
- 102100035486 Nectin-4 Human genes 0.000 claims 2
- 101710043865 Nectin-4 Proteins 0.000 claims 2
- 108010012255 Neural Cell Adhesion Molecule L1 Proteins 0.000 claims 2
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 claims 2
- 102000035195 Peptidases Human genes 0.000 claims 2
- 108091005804 Peptidases Proteins 0.000 claims 2
- 102100023832 Prolyl endopeptidase FAP Human genes 0.000 claims 2
- 102100040120 Prominin-1 Human genes 0.000 claims 2
- 102100036735 Prostate stem cell antigen Human genes 0.000 claims 2
- 239000004365 Protease Substances 0.000 claims 2
- 101710100968 Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 2
- 102100029165 Receptor-binding cancer antigen expressed on SiSo cells Human genes 0.000 claims 2
- 102100022213 Ribosome quality control complex subunit NEMF Human genes 0.000 claims 2
- 108091007561 SLC44A4 Proteins 0.000 claims 2
- 101100148976 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SDS22 gene Proteins 0.000 claims 2
- 101710173693 Short transient receptor potential channel 1 Proteins 0.000 claims 2
- 101710173694 Short transient receptor potential channel 2 Proteins 0.000 claims 2
- 102100035721 Syndecan-1 Human genes 0.000 claims 2
- 101150031162 TM4SF1 gene Proteins 0.000 claims 2
- 102100032802 Tetraspanin-8 Human genes 0.000 claims 2
- 102100026144 Transferrin receptor protein 1 Human genes 0.000 claims 2
- 102100034902 Transmembrane 4 L6 family member 1 Human genes 0.000 claims 2
- 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 claims 2
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 claims 2
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims 2
- 102000003425 Tyrosinase Human genes 0.000 claims 2
- 108060008724 Tyrosinase Proteins 0.000 claims 2
- 102100040099 U3 small nucleolar RNA-associated protein 14 homolog A Human genes 0.000 claims 2
- 102100022962 Vam6/Vps39-like protein Human genes 0.000 claims 2
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims 2
- 108010055066 asparaginylendopeptidase Proteins 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 108091007231 endothelial receptors Proteins 0.000 claims 2
- 108010087914 epidermal growth factor receptor VIII Proteins 0.000 claims 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims 2
- 102000052502 human ELANE Human genes 0.000 claims 2
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims 2
- 229940012957 plasmin Drugs 0.000 claims 2
- 108010014186 ras Proteins Proteins 0.000 claims 2
- 102000016914 ras Proteins Human genes 0.000 claims 2
- 108010020589 trehalose-6-phosphate synthase Proteins 0.000 claims 2
- 101100243447 Arabidopsis thaliana PER53 gene Proteins 0.000 claims 1
- 108010029697 CD40 Ligand Proteins 0.000 claims 1
- 102100032937 CD40 ligand Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims 1
- 102100025137 Early activation antigen CD69 Human genes 0.000 claims 1
- 102100037362 Fibronectin Human genes 0.000 claims 1
- 108010067306 Fibronectins Proteins 0.000 claims 1
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims 1
- 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 claims 1
- 102100025323 Integrin alpha-1 Human genes 0.000 claims 1
- 108010041341 Integrin alpha1 Proteins 0.000 claims 1
- 108010055795 Integrin alpha1beta1 Proteins 0.000 claims 1
- 102000000510 Integrin alpha3 Human genes 0.000 claims 1
- 108010041357 Integrin alpha3 Proteins 0.000 claims 1
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- 108010000851 Laminin Receptors Proteins 0.000 claims 1
- 102000002297 Laminin Receptors Human genes 0.000 claims 1
- 102000018697 Membrane Proteins Human genes 0.000 claims 1
- 108010052285 Membrane Proteins Proteins 0.000 claims 1
- 108010008707 Mucin-1 Proteins 0.000 claims 1
- 102100034256 Mucin-1 Human genes 0.000 claims 1
- 101100346932 Mus musculus Muc1 gene Proteins 0.000 claims 1
- 108091008874 T cell receptors Proteins 0.000 claims 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 101150080074 TP53 gene Proteins 0.000 claims 1
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims 1
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims 1
- 230000000735 allogeneic effect Effects 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000020411 cell activation Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 230000001605 fetal effect Effects 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
- 230000019491 signal transduction Effects 0.000 claims 1
- 210000004881 tumor cell Anatomy 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762462098P | 2017-02-22 | 2017-02-22 | |
| US62/462,098 | 2017-02-22 | ||
| US201762541439P | 2017-08-04 | 2017-08-04 | |
| US62/541,439 | 2017-08-04 | ||
| PCT/US2018/019281 WO2018156802A1 (en) | 2017-02-22 | 2018-02-22 | Compositions and methods for treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020508663A JP2020508663A (ja) | 2020-03-26 |
| JP2020508663A5 true JP2020508663A5 (enExample) | 2021-04-08 |
Family
ID=63253021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545731A Pending JP2020508663A (ja) | 2017-02-22 | 2018-02-22 | 癌の治療のための組成物及び方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210130494A1 (enExample) |
| EP (1) | EP3585817A4 (enExample) |
| JP (1) | JP2020508663A (enExample) |
| KR (1) | KR20200003367A (enExample) |
| CN (1) | CN110637033A (enExample) |
| AU (1) | AU2018225164A1 (enExample) |
| BR (1) | BR112019017403A2 (enExample) |
| CA (1) | CA3054304A1 (enExample) |
| CL (1) | CL2019002368A1 (enExample) |
| IL (1) | IL268814A (enExample) |
| MA (1) | MA47613A (enExample) |
| MX (1) | MX2019010040A (enExample) |
| WO (1) | WO2018156802A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7173993B2 (ja) | 2017-05-19 | 2022-11-17 | ウーシー バイオロジクス（シャンハイ）カンパニー リミテッド | 細胞傷害性ｔリンパ球関連タンパク質４（ｃｔｌａ－４）に対する新規モノクローナル抗体 |
| US11891426B2 (en) * | 2017-12-15 | 2024-02-06 | Aleta Biotherapeutics Inc. | CD19 variants |
| CN109504660B (zh) * | 2018-11-02 | 2021-08-06 | 温州启星生物技术有限公司 | 一种第四代car-t细胞及其构建方法和应用 |
| CA3119644A1 (en) | 2018-11-30 | 2020-06-04 | Dana-Farber Cancer Institute, Inc. | Chimeric antigen receptor factories and methods of use thereof |
| WO2020113063A1 (en) | 2018-11-30 | 2020-06-04 | Aleta Biotherapeutics Inc. | Single domain antibodies against cll-1 |
| CA3122773A1 (en) | 2018-12-26 | 2020-07-02 | Xilio Development, Inc. | Anti-ctla4 antibodies and methods of use thereof |
| EP3931212A1 (en) | 2019-03-01 | 2022-01-05 | Universität für Bodenkultur Wien | Stabilized extracellular domain of cd19 |
| CN110256582B (zh) * | 2019-07-10 | 2021-09-17 | 杭州普科亭生物医药有限公司 | 包含cd28和4-1bb的嵌合抗原受体及其应用 |
| CN115916817A (zh) * | 2019-12-06 | 2023-04-04 | 朱诺治疗学股份有限公司 | 针对bcma靶向结合结构域的抗独特型抗体及相关组合物和方法 |
| US20220057381A1 (en) * | 2020-06-08 | 2022-02-24 | Janssen Biotech, Inc. | Cell-based assay for determining the in vitro tumor killing activity of chimeric antigen expressing immune cells |
| EP4210733B1 (en) | 2020-09-04 | 2024-11-06 | Miltenyi Biotec B.V. & Co. KG | System for inducible expression of an adapter in immune cells |
| KR20230069961A (ko) | 2020-09-14 | 2023-05-19 | 보르 바이오파마 인크. | Cd33에 대한 단일 도메인 항체 |
| AR124414A1 (es) | 2020-12-18 | 2023-03-22 | Century Therapeutics Inc | Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable |
| CN115128267B (zh) * | 2021-03-25 | 2025-11-14 | 青岛海兰深生物科技有限公司 | 检测抗乳腺癌天然抗体的检测试剂、试剂盒及其应用 |
| US20240181055A1 (en) * | 2021-04-08 | 2024-06-06 | Crage Medical Co., Limited | Cellular immunotherapy use |
| EP4347650A1 (en) * | 2021-06-01 | 2024-04-10 | Janssen Biotech, Inc. | Anti-idiotypic antibodies against anti-cd79b antibodies |
| CA3248167A1 (en) | 2022-04-11 | 2023-10-19 | Vor Biopharma Inc. | LIAISON AGENTS AND THEIR METHODS OF USE |
| CN115725738A (zh) * | 2022-08-17 | 2023-03-03 | 深圳市龙岗区耳鼻咽喉医院 | 一种长链非编码rna分子标志物组合及其应用 |
| WO2024238565A1 (en) | 2023-05-15 | 2024-11-21 | Vor Biopharma Inc. | Egf-like module containing mucin-like hormone-like 2 (erm2) binding agents and methods of use thereof |
| EP4470555A1 (en) | 2023-05-31 | 2024-12-04 | Miltenyi Biotec B.V. & Co. KG | Anti-tag chimeric antigen receptors with specificity for mutated peptides derived from human fgfr2 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997034636A1 (en) * | 1996-03-20 | 1997-09-25 | Immunomedics, Inc. | Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| US20060018911A1 (en) * | 2004-01-12 | 2006-01-26 | Dana Ault-Riche | Design of therapeutics and therapeutics |
| GB0404187D0 (en) * | 2004-02-25 | 2004-03-31 | Biotransformations Ltd | Binding agents |
| US20090304719A1 (en) * | 2007-08-22 | 2009-12-10 | Patrick Daugherty | Activatable binding polypeptides and methods of identification and use thereof |
| RU2636046C2 (ru) * | 2009-01-12 | 2017-11-17 | Сайтомкс Терапьютикс, Инк | Композиции модифицированных антител, способы их получения и применения |
| EP2723380B1 (en) * | 2011-06-24 | 2019-08-21 | Stephen D. Gillies | Light chain immunoglobulin fusion proteins and methods of use thereof |
| GB201203442D0 (en) * | 2012-02-28 | 2012-04-11 | Univ Birmingham | Immunotherapeutic molecules and uses |
| CA2913052A1 (en) * | 2013-05-24 | 2014-11-27 | Board Of Regents, The University Of Texas System | Chimeric antigen receptor-targeting monoclonal antibodies |
| WO2015121454A1 (en) * | 2014-02-14 | 2015-08-20 | Cellectis | Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells |
| CA2955947A1 (en) * | 2014-07-25 | 2016-01-28 | Cytomx Therapeutics, Inc. | Anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable anti-cd3 antibodies, and methods of using the same |
| CN107709356A (zh) * | 2015-06-26 | 2018-02-16 | 南加利福尼亚大学 | 用于肿瘤特异性活化的掩蔽嵌合抗原受体t细胞 |
| US10508143B1 (en) * | 2015-10-30 | 2019-12-17 | Aleta Biotherapeutics Inc. | Compositions and methods for treatment of cancer |
| WO2017162587A1 (en) * | 2016-03-22 | 2017-09-28 | F. Hoffmann-La Roche Ag | Protease-activated t cell bispecific molecules |
| CA3021634A1 (en) * | 2016-04-15 | 2017-10-19 | Zymeworks Inc. | Multi-specific antigen-binding constructs targeting immunotherapeutics |
-
2018
- 2018-02-22 AU AU2018225164A patent/AU2018225164A1/en not_active Abandoned
- 2018-02-22 WO PCT/US2018/019281 patent/WO2018156802A1/en not_active Ceased
- 2018-02-22 BR BR112019017403A patent/BR112019017403A2/pt not_active IP Right Cessation
- 2018-02-22 US US16/487,750 patent/US20210130494A1/en not_active Abandoned
- 2018-02-22 CA CA3054304A patent/CA3054304A1/en not_active Abandoned
- 2018-02-22 EP EP18758228.3A patent/EP3585817A4/en not_active Withdrawn
- 2018-02-22 MX MX2019010040A patent/MX2019010040A/es unknown
- 2018-02-22 KR KR1020197027551A patent/KR20200003367A/ko not_active Withdrawn
- 2018-02-22 CN CN201880025774.6A patent/CN110637033A/zh active Pending
- 2018-02-22 MA MA047613A patent/MA47613A/fr unknown
- 2018-02-22 JP JP2019545731A patent/JP2020508663A/ja active Pending
-
2019
- 2019-08-21 IL IL26881419A patent/IL268814A/en unknown
- 2019-08-22 CL CL2019002368A patent/CL2019002368A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020508663A5 (enExample) | ||
| JP2020504628A5 (enExample) | ||
| JP2022515194A5 (enExample) | ||
| JP2018518978A5 (enExample) | ||
| JP7267321B2 (ja) | 改善された特異性を有する改変型ｔリンパ球 | |
| US11629335B2 (en) | Methods of improving vector transduction efficiency into T lymphocytes | |
| US11806365B2 (en) | Modified T lymphocytes comprising a CD52 antibody-inducible caspase and methods of apoptosis | |
| AU2016343809B2 (en) | Compositions and methods for treatment of cancer | |
| CN105418765B (zh) | Cd19靶向性的嵌合抗原受体和nkt细胞及其制法和应用 | |
| EP3575325A1 (en) | Multi-target chimeric antigen receptor | |
| JP2020504628A (ja) | 多官能性タンパク質 | |
| CN110637033A (zh) | 用于治疗癌症的组合物和方法 | |
| AU2013204923A1 (en) | Modified t lymphocytes having improved specificity | |
| JP2023532080A5 (enExample) | ||
| CN106478823B (zh) | Her1靶向性的嵌合抗原受体和nkt细胞及其制法和应用 | |
| WO2025072081A1 (en) | Enriched t-cell populations | |
| Atherton et al. | Abstract B096: Oncolytic vaccination for HPV induced cancer | |
| NZ712373B2 (en) | Modified t lymphocytes | |
| HK1234782B (en) | Methods of improving vector transduction efficiency into t lymphocytes | |
| HK1234782A1 (en) | Methods of improving vector transduction efficiency into t lymphocytes | |
| HK1218049B (en) | Modified t lymphocytes having improved specificity |